First Header Logo Second Header Logo

Mustafa S. Siddiqui MD

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentNeurology
Address
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentNeurological Surgery

    TitleProfessor
    InstitutionWake Forest School of Medicine
    DepartmentWake Forest Institute for Regenerative Medicine


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chaudhuri KR, Kovács N, Pontieri FE, Aldred J, Bourgeois P, Davis TL, Cubo E, Anca-Herschkovitsch M, Iansek R, Siddiqui MS, Simu M, Bergmann L, Ballina M, Kukreja P, Ladhani O, Jia J, Standaert DG. Levodopa Carbidopa Intestinal Gel in Advanced Parkinson's Disease: DUOGLOBE Final 3-Year Results. J Parkinsons Dis. 2023 Jun 05. PMID: 37302039.
      Citations:    
    2. Ruckart KW, Wilson C, Moya-Mendez ME, Madden LL, Laxton A, Siddiqui MS. Effect of Ventral Intermediate Nucleus Deep Brain Stimulation on Vocal Tremor in Essential Tremor. Tremor Other Hyperkinet Mov (N Y). 2023; 13:13. PMID: 37152623.
      Citations:    
    3. Duffley G, Szabo A, Lutz BJ, Mahoney-Rafferty EC, Hess CW, Ramirez-Zamora A, Zeilman P, Foote KD, Chiu S, Pourfar MH, Goas Cnp C, Wood JL, Haq IU, Siddiqui MS, Afshari M, Heiry M, Choi J, Volz M, Ostrem JL, San Luciano M, Niemann N, Billnitzer A, Savitt D, Tarakad A, Jimenez-Shahed J, Aquino CC, Okun MS, Butson CR. Interactive mobile application for Parkinson's disease deep brain stimulation (MAP DBS): An open-label, multicenter, randomized, controlled clinical trial. Parkinsonism Relat Disord. 2023 Apr; 109:105346. PMID: 36966051.
      Citations:    
    4. DiMarco E, Sadibolova R, Jiang A, Liebenow B, Jones RE, Ul Haq I, Siddiqui MS, Terhune DB, Kishida KT. Time perception reflects individual differences in motor and non-motor symptoms of Parkinson's disease. bioRxiv. 2023 Mar 02. PMID: 36909605.
      Citations:    
    5. Liebenow B, Jiang A, DiMarco E, Wilson T, Siddiqui MS, Ul Haq I, Laxton AW, Tatter SB, Kishida KT. Intracranial subsecond dopamine measurements during a "sure bet or gamble" decision-making task in patients with alcohol use disorder suggest diminished dopaminergic signals about relief. Neurosurg Focus. 2023 Feb; 54(2):E3. PMID: 36724520.
      Citations:    
    6. Soileau MJ, Pagan FL, Fasano A, Rodriguez-Cruz R, Yan CH, Gupta NR, Teigland CL, Pulungan Z, Schinkel JK, Kandukuri PL, Ladhani OA, Siddiqui MS. Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's Disease. Neurol Ther. 2023 Apr; 12(2):459-478. PMID: 36652111.
      Citations:    
    7. Liebenow B, Williams M, Wilson T, Haq IU, Siddiqui MS, Laxton AW, Tatter SB, Kishida KT. Intracranial approach for sub-second monitoring of neurotransmitters during DBS electrode implantation does not increase infection rate. PLoS One. 2022; 17(8):e0271348. PMID: 35994460.
      Citations:    
    8. Soileau MJ, Pagan F, Fasano A, Rodriguez-Cruz R, Wang L, Kandukuri PL, Yan CH, Alobaidi A, Bao Y, Kukreja P, Oh M, Siddiqui MS. Comparative Effectiveness of Carbidopa-Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson's Disease-Related Pill Burden Reduction in Advanced Parkinson's Disease: A Retrospective Real-World Cohort Study. Neurol Ther. 2022 Jun; 11(2):851-861. PMID: 35441973.
      Citations:    
    9. Kovács N, Bergmann L, Anca-Herschkovitsch M, Cubo E, Davis TL, Iansek R, Siddiqui MS, Simu M, Standaert DG, Chaudhuri KR, Bourgeois P, Gao T, Kukreja P, Pontieri FE, Aldred J. Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel. J Parkinsons Dis. 2022; 12(3):917-926. PMID: 34974438.
      Citations:    
    10. Siddiqui MS, Jimenez-Shahed J, Mari Z, Walter BL, De Jesus S, Panov F, Schwalb JM, York MK, Sarva H, Bertoni JM, Patel N, Zhang L, McInerney J, Rosenow JM. North American survey on impact of the COVID-19 pandemic shutdown on DBS care. Parkinsonism Relat Disord. 2021 Oct 18; 92:41-45. PMID: 34688029.
      Citations:    
    11. Standaert DG, Aldred J, Anca-Herschkovitsch M, Bourgeois P, Cubo E, Davis TL, Iansek R, Kovács N, Pontieri FE, Siddiqui MS, Simu M, Bergmann L, Kukreja P, Robieson WZ, Chaudhuri KR. DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease. Mov Disord Clin Pract. 2021 Oct; 8(7):1061-1074. PMID: 34631942.
      Citations:    
    12. Ruckart KW, Moya-Mendez ME, Nagatsuka M, Barry JL, Siddiqui MS, Madden LL. Comprehensive Evaluation of Voice-Specific Outcomes in Patients With Essential Tremor Before and After Deep Brain Stimulation. J Voice. 2020 Oct 16. PMID: 33071149.
      Citations:    
    13. Aldred J, Anca-Herschkovitsch M, Antonini A, Bajenaru O, Bergmann L, Bourgeois P, Cubo E, Davis TL, Iansek R, Kovács N, Kukreja P, Onuk K, Pontieri FE, Robieson W, Siddiqui MS, Simu M, Standaert DG, Chaudhuri KR. Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE. Neurodegener Dis Manag. 2020 10; 10(5):309-323. PMID: 32873195.
      Citations:    
    14. Vitek JL, Jain R, Chen L, Tröster AI, Schrock LE, House PA, Giroux ML, Hebb AO, Farris SM, Whiting DM, Leichliter TA, Ostrem JL, San Luciano M, Galifianakis N, Verhagen Metman L, Sani S, Karl JA, Siddiqui MS, Tatter SB, Ul Haq I, Machado AG, Gostkowski M, Tagliati M, Mamelak AN, Okun MS, Foote KD, Moguel-Cobos G, Ponce FA, Pahwa R, Nazzaro JM, Buetefisch CM, Gross RE, Luca CC, Jagid JR, Revuelta GJ, Takacs I, Pourfar MH, Mogilner AY, Duker AP, Mandybur GT, Rosenow JM, Cooper SE, Park MC, Khandhar SM, Sedrak M, Phibbs FT, Pilitsis JG, Uitti RJ, Starr PA. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. 2020 06; 19(6):491-501. PMID: 32470421.
      Citations:    
    15. Boyd JT, Zadikoff C, Benesh JA, Zamudio J, Robieson WZ, Kukreja P, Yokoyama M, Siddiqui MS. A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies. Clin Park Relat Disord. 2020; 2:25-34. PMID: 34316616.
      Citations:    
    16. Finger ME, Madden LL, Haq IU, McLouth CJ, Siddiqui MS. Analysis of the prevalence and onset of dysphonia and dysphagia symptoms in movement disorders at an academic medical center. J Clin Neurosci. 2019 Jun; 64:111-115. PMID: 30948311.
      Citations:    
    17. Finger ME, Siddiqui MS, Morris AK, Ruckart KW, Wright SC, Haq IU, Madden LL. Auditory-Perceptual Evaluation of Deep Brain Stimulation on Voice and Speech in Patients With Dystonia. J Voice. 2020 Jul; 34(4):636-644. PMID: 30879706.
      Citations:    
    18. Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Sapan CV, Eidelberg D, During MJ, Kaplitt MG, Feigin A. Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease. JCI Insight. 2017 04 06; 2(7):e90133. PMID: 28405611.
      Citations:    
    19. Haq IU, Siddiqui MS, Tate J, Okun MS. . Youmans & Winn Neurological Surgery. Movement Disorders. 2016.
    20. Strowd RE, Herco M, Passmore-Griffin L, Avery B, Haq I, Tatter SB, Tate J, Siddiqui MS. Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study. Clin Neurol Neurosurg. 2016 Jan; 140:38-42. PMID: 26619034.
      Citations:    
    21. Syed AS, Ali F, Sher K, Ikram A, Soomor B. (Siddiqui M advisory panel participant). National Guidelines for Diagnosis and Management of Parkinson’s Disease in Pakistan. 2015.
    22. Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results. Mov Disord. 2015 Apr; 30(4):500-9. PMID: 25545465.
      Citations:    
    23. Biaggioni I, Freeman R, Mathias CJ, Low P, Hewitt LA, Kaufmann H. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension. 2015 Jan; 65(1):101-7. PMID: 25350981.
      Citations:    
    24. Espeland MA, Bryan RN, Goveas JS, Robinson JG, Siddiqui MS, Liu S, Hogan PE, Casanova R, Coker LH, Yaffe K, Masaki K, Rossom R, Resnick SM. Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies. Diabetes Care. 2013 Jan; 36(1):90-7. PMID: 22933440.
      Citations:    
    25. LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, Sarkar A, Siddiqui MS, Tatter SB, Schwalb JM, Poston KL, Henderson JM, Kurlan RM, Richard IH, Van Meter L, Sapan CV, During MJ, Kaplitt MG, Feigin A. AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol. 2011 Apr; 10(4):309-19. PMID: 21419704.
      Citations:    
    26. Cheng EM, Tonn S, Swain-Eng R, Factor SA, Weiner WJ, Bever CT. Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2010 Nov 30; 75(22):2021-7. PMID: 21115958.
      Citations:    
    27. Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord. 2011 Jan; 26(1):90-9. PMID: 21322021.
      Citations:    
    28. Haq IU, Foote KD, Goodman WK, Ricciuti N, Ward H, Sudhyadhom A, Jacobson CE, Siddiqui MS, Okun MS. A case of mania following deep brain stimulation for obsessive compulsive disorder. Stereotact Funct Neurosurg. 2010; 88(5):322-8. PMID: 20714212.
      Citations:    
    29. Strowd RE, Cartwright MS, Okun MS, Haq I, Siddiqui MS. Pseudobulbar affect: prevalence and quality of life impact in movement disorders. J Neurol. 2010 Aug; 257(8):1382-7. PMID: 20376475.
      Citations:    
    30. Strowd RE, Cartwright MS, Passmore LV, Ellis TL, Tatter SB, Siddiqui MS. Weight change following deep brain stimulation for movement disorders. J Neurol. 2010 Aug; 257(8):1293-7. PMID: 20221769.
      Citations:    
    31. Haq IU, Foote KD, Goodman WG, Wu SS, Sudhyadhom A, Ricciuti N, Siddiqui MS, Bowers D, Jacobson CE, Ward H, Okun MS. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. Neuroimage. 2011 Jan; 54 Suppl 1:S247-55. PMID: 20226259.
      Citations:    
    32. Morishita T, Foote KD, Wu SS, Jacobson CE, Rodriguez RL, Haq IU, Siddiqui MS, Malaty IA, Hass CJ, Okun MS. Brain penetration effects of microelectrodes and deep brain stimulation leads in ventral intermediate nucleus stimulation for essential tremor. J Neurosurg. 2010 Mar; 112(3):491-6. PMID: 19663554.
      Citations:    
    33. Siddiqui MS, Haq IU, Okun MS. Deep brain stimulation in movement disorders. Continuum (Minneap Minn). 2010 Feb; 16(1 Movement Disorders):110-30. PMID: 22810183.
      Citations:    
    34. Mann JM, Foote KD, Garvan CW, Fernandez HH, Jacobson CE, Rodriguez RL, Haq IU, Siddiqui MS, Malaty IA, Morishita T, Hass CJ, Okun MS. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry. 2009 Jul; 80(7):794-7. PMID: 19237386.
      Citations:    
    35. Siddiqui MS, Fernandez HH, Garvan CW, Kirsch-Darrow L, Bowers D, Rodriguez RL, Jacobson CE, Rosado C, Vaidyanathan S, Foote KD, Okun MS. Inappropriate crying and laughing in Parkinson disease and movement disorders. World J Biol Psychiatry. 2009; 10(3):234-40. PMID: 18609421.
      Citations:    
    36. Siddiqui MS, Ellis TL, Tatter SB, Okun MS. Deep brain stimulation: treating neurological and psychiatric disorders by modulating brain activity. NeuroRehabilitation. 2008; 23(1):105-13. PMID: 18356594.
      Citations:    
    37. Siddiqui MS*, Ellis T, Tatter SS, Foote KD, Okun MS. Deep Brain Stimulation: Patient Selection in Parkinson’s Disease, other Movement Disorders, and Neuropsychiatric Disorders. Deep Brain Stimulation in Neurological and Psychiatric Disorders. Current Clinical Neurology 2008 (Humana Press). 2008.
    38. Siddiqui MS*, Okun MS. . Deep Brain Stimulation in Parkinson's disease. Continuum Neurology, American Academy of Neurology. 2007; 1(13):39-57.
    39. Haq I, Siddiqui MS; Zailman P, Okun MS. Deep brain stimulation in movement disorders. Medlink Neurology, Movement Disorders. 2007.
    40. Qureshi AI, Suri MF, Saad M, Hopkins LN. Educational attainment and risk of stroke and myocardial infarction. Med Sci Monit. 2003 Nov; 9(11):CR466-73. PMID: 14586271.
      Citations:    
    41. Saad M*, Qureshi AI. The National Organization for Rare Diseases, (NORD). The NORD Guide to Rare Disorders. Glioblastoma Multiforme. Guide to Rare Disorders. 2003; 384-385.
    42. Qureshi AI, Siddiqui AM, Suri MF, Kim SH, Ali Z, Yahia AM, Lopes DK, Boulos AS, Ringer AJ, Saad M, Guterman LR, Hopkins LN. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery. 2002 Nov; 51(5):1319-27; discussion 1327-9. PMID: 12383381.
      Citations:    
    43. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke. 2002 Jul; 33(7):1916-9. PMID: 12105375.
      Citations:    
    44. Qureshi AI, Suri MF, Sung GY, Straw RN, Yahia AM, Saad M, Guterman LR, Hopkins LN. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002 Apr; 50(4):749-55; discussion 755-6. PMID: 11904025.
      Citations:    
    45. Qureshi AI, Suri FK, Ali Z, Saad M. Investigation and Early Treatment of Acute Stroke. Journal of the Islamic Medical Association of North America. 2001; 33:72-76.
    46. Saad M*, Suri FK, Ali Z, Qureshi AI. Risk Factors for Stroke. Journal of the Islamic Medical Association of North America. 2001; 33:68-71.
    Siddiqui's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (139)
    Explore
    _
    Co-Authors (8)
    Explore
    _
    Similar People (53)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _